PATH EX

PATH EX, Inc. (www.pathex.co) is a privately held medical device company pioneering a breakthrough approach to sepsis treatment with its innovative CycloPE® device. CycloPE® is designed to directly capture and remove bacteria from the bloodstream, offering a rapid, targeted solution to combat life-threatening infections.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Pharmaceutical industry

Artificial Intelligence (AI)

Health technology

Location

Nashville, Tennessee

B2X

CEO

Sinead E. Miller

Number of Employees (Ranges)

1 – 10

Investors

Fitz Gate Ventures

TMC Venture Fund

IAG Capital Partners

Total Funding Amount (USD)

5,000,000

Latest Funding Round Date

May 8, 2025

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

5,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like PATH EX

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.